The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- RT @ALIVER_EU: Organ transplants hit an all-time high in 2017. But it’s a bittersweet win t.co/gDEvpWdtgz Time ago 2 Days via Twitter for iPhone
- RT @autostem2020: Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – #MSC Model Case Study https:/… Time ago 2 Days via Twitter for iPhone
- Stem cell-rich cord blood donations could increase by 'nudging' parents, study suggests t.co/5bT50Sacfa Time ago 6 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.